Volatile terpenoids as potential drug leads in Alzheimer’s disease

• Main Authors: Wojtunik-Kulesza Karolina A., Targowska-Duda Katarzyna, Klimek Katarzyna, Ginalska Grażyna, Jóźwiak Krzysztof, Waksmundzka-Hajnos Monika, Cieśla Łukasz
• Format: Article
• Language: English
• Published: De Gruyter 2017-12-01
• Series: Open Chemistry
• Subjects: terpenes; ache inhibitor; molecular docking; mtt assay; acetylcholinesterase
• Online Access: https://doi.org/10.1515/chem-2017-0040

Alzheimer’s disease (AD) is by far the most prevalent of all known forms of dementia. Despite wide-spread research, the main causes of emergence and development of AD have not been fully recognized. Natural, low-molecular, lipophilic terpenoids constitute an interesting group of secondary plant metabolites, that exert biological activities of possible use in the prevention and treatment of AD. In order to identify secondary metabolites possessing both antioxidant activity and the potential to increase the level of acetylcholine, selected terpenoids have been screened for possible acetylcholinesterase inhibitory activity by use of two methods, namely Marston (chromatographic assay) and Ellman (spectrophotometric assay). In order to describe the interaction between terpenes and AChE active gorge, molecular docking simulations were performed. Additionally, all analyzed terpenes were also evaluated for their cytotoxic properties against two normal cell lines using MTT assay. The obtained results show that: carvone (6), pulegone (8) and γ-terpinene (7) possess desirable AChE inhibitory activity. MTT assay revealed low or lack of cytotoxicity of these metabolites. Thus, among the investigated terpenes, carvone (6), pulegone (8) and y-terpinene (7) can be recognized as compounds with most promising activities in the development of multi-target directed ligands.